SM
Sabby Management’s Enlivex Therapeutics ENLV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-12,925
| Closed | -$65K | – | 80 |
|
|
2020
Q2 | $65K | Sell |
12,925
-432,748
| -97% | -$2.18M | 0.01% | 43 |
|
|
2020
Q1 | $2.09M | Buy |
+445,673
| New | +$2.09M | 0.87% | 4 |
|
|
2017
Q2 | – | Sell |
-219,905
| Closed | -$167K | – | 131 |
|
|
2017
Q1 | $167K | Sell |
219,905
-440,252
| -67% | -$334K | 0.01% | 107 |
|
|
2016
Q4 | $687K | Sell |
660,157
-123,900
| -16% | -$129K | 0.04% | 73 |
|
|
2016
Q3 | $1.36M | Sell |
784,057
-46,196
| -6% | -$79.9K | 0.05% | 53 |
|
|
2016
Q2 | $1.33M | Sell |
830,253
-303,684
| -27% | -$486K | 0.07% | 55 |
|
|
2016
Q1 | $2.82M | Buy |
+1,133,937
| New | +$2.82M | 0.14% | 28 |
|